Clinical trial
Kinetics of B Cell Response in Infants Menjugate Vaccination
NCT00310700 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00310700 |
|---|---|
| Title | Kinetics of B Cell Response in Infants Menjugate Vaccination |
| Official title | A Phase IV, Single Centre, Open-label Study to Investigate the Kinetics of the B Cell Response to the First and the Third Immunization With Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Infants at 2, 3 and 4 Months of Age |
| Lead sponsor | Novartis, Industry |
| Collaborators | Novartis Vaccines Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Prevention of Meningococcal Infection |
| Intervention type | Biological |
| Interventions | Meningococcal C conjugate vaccine |
| Enrollment | 75 |
| Start date | May 1, 2005 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Apr 4, 2006 |
| Last update posted | Sep 19, 2014 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: